Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most prevalent primary liver malignancy worldwide and is associated with a poor prognosis. Sophisticated molecular mechanisms and biological characteristics need to be explored to gain a better understanding of HCC. The role of metabolites in cancer immunometabo...
Main Authors: | Wenhui Zhang, Yu Zhao, Qiang He, Ren Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1211126/full |
Similar Items
-
Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
by: May G. Akl, et al.
Published: (2023-01-01) -
Succinate metabolism: a promising therapeutic target for inflammation, ischemia/reperfusion injury and cancer
by: Wenhui Zhang, et al.
Published: (2023-09-01) -
Methods of Attenuating Ischemia-Reperfusion Injury in Liver Transplantation for Hepatocellular Carcinoma
by: Łukasz Masior, et al.
Published: (2021-07-01) -
Radiological‐histopathological discordance in patients transplanted for HCC and its impact on post‐transplant outcomes
by: Islam B. Mohamed, et al.
Published: (2023-07-01) -
Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions
by: Afolarin A. Otunla, et al.
Published: (2024-02-01)